Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 1997

View Archived Issues

Company Profile: Mercury Therapeutics

Alexion issued two patents covering technology for xenotransplantation products

Viracept now available in Canada through expanded access program

FDA approves Mylan's generic extended-release diltiazem

Roche gains access to combinatorial libraries

Aquila's QS-21 enhances immune response of DNA vaccines in preclinical studies

Smith & Nephew to evaluate DynaGen's Orthodyn

Cel-Sci's HGP-30 AIDS vaccine shows recognition of major HIV subtypes

Nanogen and Becton Dickinson enter diagnostic collaboration

Dermik introduces combination acne therapy in South Africa

Lilly and Scios AD collaboration

Orphan Medical's medicated chewing gum reduces stomach levels of H. pylori

CytoMed initiates phase II trials of CMI-392

Medtronic and Cephalon to copromote Intrathecal Baclofen Therapy

Nippon Shinyaku prepares improved ciclosporin derivatives

Antiparasitic depsipeptides from Meiji Seika

Wakunaga prepares novel antibacterial agents

Lilly discloses selective beta3-agonists

Bradykinin antagonists from Fujisawa

Improved analgesic/antiinflammatory urea derivatives disclosed by Novartis

MS&D reports potent and selective 5-HT1Dalpha agonists

Cinchonine shown to reverse multidrug resistance

Preclinical and preliminary clinical data reported for LU-103793

ONYX-015 demonstrates in vitro and in vivo efficacy

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

BM-92.0700: a promising anticancer clinical candidate

Novel EGF receptor TK inhibitor described by Mitsubishi

Natural cancer immunotherapeutic discovered by Yonsei University researchers

New class of topo I inhibitors designed for oral administration

Anti-HBV/anti-HIV L-nucleoside analogue described

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...